• 1 Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors.- 2 Antidepressant Properties of Specific Serotonin-Noradrenaline Reuptake Inhibitors.- 3 5-HT-Moduline: Novel Therapeutic Strategy for Antidepressant Action.- 4 Reversible Inhibitors of Monoamine Oxidase A (RIMAs): Where Can We Go from Here?.- 5 Calcium Channel Antagonists in Mood Disorders.- 6 Functional NMDA Antagonists: A New Class of Antidepressant Agents.- 7 Is an Adaptation of NMDA Receptors an Obligatory Step in Antidepressant Action?.- 8 NMDA Receptors and Affective Disorders.- 9 The Potential Contribution of Sigma Receptors to Antidepressant Actions.- 10 A Role for CREB in Antidepressant Action.- 11 Antidepressants: Beyond the Synapse.- 12 Animal Models to Detect Antidepressants: Are New Strategies Necessary to Detect New Agents?.- 13 Molecular Strategies to Novel Antidepressant Discovery.

"This is a timely, much needed addition to the library of a psychopharmacology researcher who is interested in developing new studies in the field of antidepressant functioning or who needs a thorough update on cutting edge antidepressant pharmacology and theory."-Doody's Health Sciences Book Review Journal